Fulcrum Therapeutics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Fulcrum Therapeutics stock has a consensus rating of "Buy" and an average price target of $18.9. The average 1-year stock price forecast is 177.13% higher than the current stock price, while the lowest is $8.00 (+17.30%) and the highest is $25 (+266.57%).

Price Target: $18.9 (+177.13%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$18.9	$20.5	$25
Change	+17.30%	+177.13%	+200.59%	+266.57%

Analyst Ratings

The average analyst rating for Fulcrum Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	6	6	6	6
Buy	1	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	9	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tazeen Ahmad Bank of America Securities	Bank of America Securities	Sell Reiterates $7 → $8	Sell	Reiterates	$7 → $8	+17.30%	May 8, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $18	Buy	Maintains	$18	+163.93%	May 4, 2026
Andrew Fein H.C. Wainwright	H.C. Wainwright	Buy Reiterates $25	Buy	Reiterates	$25	+266.57%	Apr 28, 2026
Matthew Biegler Oppenheimer	Oppenheimer	Buy Reiterates $15	Buy	Reiterates	$15	+119.94%	Apr 28, 2026
Gregory Renza Truist Financial	Truist Financial	Buy Reiterates $17	Buy	Reiterates	$17	+149.27%	Apr 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.18

from -1.18

EPS Next Year

-1.34

from -1.18

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	19.16M	6.34M	2.81M	80.00M	-	-	-
Revenue Growth	117.19%	-66.91%	-55.77%	2,752.05%	-	-	-
EPS	-2.29	-2.44	-1.59	-0.16	-1.18	-1.18	-1.34
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.08	-0.96
Avg	-1.18	-1.34
Low	-1.52	-1.87

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.